COPD and Asthma Can Delay Lung Cancer Diagnosis by Masking Early Symptoms
Patients with chronic conditions like COPD and asthma are diagnosed with lung cancer significantly later than those without these conditions.
Category: Lung Cancer
Lung Cancer
Latest
Lung Cancer
Latest
High-Crime Areas May Drive Lung Cancer Progression
Scientists have linked high levels of violent crime to aggressive lung cancer tumors, suggesting chronic stress as a potential driver.
Lung Cancer
Latest
Former Smokers Who Vape at Greater Risk of Lung Cancer
Former cigarette smokers who use e-cigarettes or vaping devices may be at higher risk for lung cancer than those who don’t vape, according to research presented at ATS 2024. Â
High-dose Radiotherapy Plus Chemotherapy Effective NSCLC Therapy
Using high doses of radiation while integrating stereotactic ablative radiotherapy concurrently with chemotherapy is safe and effective in treating people with locally advanced non-small cell lung cancer that is not suitable for surgery.
Read More
Inhalable Sensors Show Promise for Early Lung Cancer Detection
Using a new technology developed at MIT, diagnosing lung cancer could become as easy as inhaling nanoparticle sensors and then taking a urine test that reveals whether a tumor is present.
Read More
Lung Cancer Screenings Lead to More Procedures and Complications Than Expected
A study of more than 9,000 persons screened for lung cancer found that rates of downstream procedures and complications associated with screening are substantially higher in routine clinical practice than previously observed.
Read More
Interventional Pulmonology Section Added to Baltimore Health System
The Lung Center at Mercy Medical Center (Baltimore, Md) is expanding to include Interventional Pulmonology, including a dedicated pulmonary nodule program, pleural disease clinic, improved lung cancer screening, and community outreach.
Read More
Liquid Biopsy Predicts Immunotherapy Response in Advanced Lung Cancer
Liquid biopsy to study genetic material from tumors shed into the bloodstream together with immune cells helps predict response to immunotherapy.
Read More
Dupilumab May Help Treat Lung Cancer, Reduce Tumors
Combining immunotherapy with dupilumab boosted lung cancer patients’ immune systems, with one out of the six experiencing significant tumor reduction, according to findings published in Nature.
Read More
Could Dupilumab Help Treat Lung Cancer?
In an early parallel study in humans with non-small cell lung cancer, combining immunotherapy with dupilumab boosted patients’ immune systems, with one out of the six experiencing significant tumor reduction. Â
Read More
AstraZeneca’s NSCLC Therapy Imfinzi Misses Primary Endpoint in Ph3 Study
AstraZeneca’s Imfinzi (durvalumab) concurrently administered with chemoradiotherapy did not achieve a Phase 3 primary endpoint of progression-free survival versus CRT alone for the treatment of patients with unresectable, Stage III non-small cell lung cancer.
Read More
FDA Approves Bristol Myers’ Non-Small Cell Lung Cancer Drug
Augtyro was approved for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer.
Read More
Lung Cancer Survival Rates ‘Improving for Everyone,’ National Report Reveals
The American Lung Association’s 2023 “State of Lung Cancer” report reveals improvement in five-year survival rate across the US, including for people of color.
Read More
Early CT Screening Skyrockets Long-term Lung Cancer Survival Rates
Diagnosing early-stage lung cancer with low-dose computed tomography screening drastically improves its cure rate measured over a 20-year period, according to a large-scale study.
Read More
New Lung Cancer Screening Guideline Expands Eligibility
Nearly 5 million US adults who smoke and formerly smoked are now recommended for testing.
Read More